Clinical Trial Update: Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting results of Abraxane with or without mifepristone in advanced glucocorticoid receptor-positive triple-negative breast cancer, with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Mifepristone (mifepristone)

Snippet

Sponsor: University of Chicago | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-02-16